pHion Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Bankr. Admin/Reorg
pHion Therapeutics General Information
Description
Developer of a pipeline of therapeutic and prophylactic vaccines designed to treat viral infections and oncology. The company develops vaccines that utilize a peptide-based drug delivery system to enhance in vitro performance, eliminate issues with nucleic acid size and associated scalability of drug formulation and increase the therapeutic potential of nucleic acid vaccines, enabling researchers to have the required amount of therapeutic effect of drugs on specific tissues and cells to help patients fight different types of diseases.
Contact Information
Website
www.phiontx.co.ukCorporate Office
- Catalyst Concourse Building 2
- 20 Queen's Road Titanic Quarter
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
Corporate Office
- Catalyst Concourse Building 2
- 20 Queen's Road Titanic Quarter
- Belfast BT3 9DT
- Northern Ireland, United Kingdom
pHion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Bankruptcy: Admin/Reorg | 23-Sep-2024 | Completed | Bankruptcy: Admin/Reorg | |||
| 10. Later Stage VC | 01-Jun-2023 | Completed | Pre-Clinical Trials | |||
| 9. Grant | 01-Jun-2021 | Completed | Pre-Clinical Trials | |||
| 8. Accelerator/Incubator | 14-May-2021 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jan-2021 | Completed | Pre-Clinical Trials | |||
| 6. Grant | 01-Jun-2020 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Feb-2020 | Completed | Pre-Clinical Trials | |||
| 4. Grant | 01-Sep-2019 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC | 04-Mar-2019 | $6.13M | $6.13M | Completed | Pre-Clinical Trials | |
| 2. Grant | 23-Nov-2017 | $149K | Completed | Pre-Clinical Trials |
pHion Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Preferred | ||||||||
| A Preferred | ||||||||
| A Preferred | 422,761 | $0.000012 | $1.75 | $1.75 | 1x | $1.75 | 5.08% |
pHion Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
pHion Therapeutics Patents
pHion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202207281-D0 | Vaccine | Pending | 18-May-2022 | ||
| GB-2618818-A | Vaccine | Pending | 18-May-2022 | ||
| WO-2023222757-A1 | Vaccine for preventing or treating cronavirus infection | Inactive | 18-May-2022 | ||
| EP-4479077-A1 | Mrna vaccine | Inactive | 18-Feb-2022 | ||
| GB-202202186-D0 | Mrna vaccine | Pending | 18-Feb-2022 | A61K39/12 |
pHion Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
pHion Therapeutics FAQs
-
When was pHion Therapeutics founded?
pHion Therapeutics was founded in 2017.
-
Where is pHion Therapeutics headquartered?
pHion Therapeutics is headquartered in Belfast, United Kingdom.
-
What is the size of pHion Therapeutics?
pHion Therapeutics has 11 total employees.
-
What industry is pHion Therapeutics in?
pHion Therapeutics’s primary industry is Drug Discovery.
-
Is pHion Therapeutics a private or public company?
pHion Therapeutics is a Private company.
-
What is pHion Therapeutics’s current revenue?
The current revenue for pHion Therapeutics is .
-
How much funding has pHion Therapeutics raised over time?
pHion Therapeutics has raised $12.5M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
